Second Sight Medical (EYES) Picks Up Chatter Ahead of CNBC Coverage

While off the highs, traders are getting chatty about today's IPO for Second Sight Medical Products (NASDAQ: EYES) as it is expected to be highlighted on CNBC in a little while. Shares are up 105% at last check to $18.50 after pricing at $9.

You May Also Be Interested In

• Trump: Iran cannot have, in any way, shape, or form, a nuclear weapon
• Anthropic CFO Krishna Rao is leading early IPO meetings with investors and has not discussed valuation - CNBC
• Boeing lands two U.S. defense contracts worth over $711M